Lazard Files Prospectus Supplement for Resale of Up to 9.4 Million Shares
Lazard, Inc. filed a prospectus supplement regarding the potential resale of over 9.4 million shares issued as part of its acquisition of Campbell Lutyens Holdings.
Stocks · News reference
Lazard & Co., Limited Acts as Financial Adviser in Bodycote Acquisition
Lazard & Co., Limited is serving as the exclusive financial adviser to BidCo and Veritas in connection with the acquisition of Bodycote.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — Lazard, Inc. (LAZ)
Filed: 2026-11-06 AccNo: 0001628280-26-071761 Size: 150 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Lazard Acts as Financial Advisor to DTE Energy in Asset Sale
Lazard is serving as the exclusive financial advisor to DTE Energy regarding the sale of its DTE Vantage assets.
Lazard Serves as Financial Advisor to ARRAY's Special Committee
Lazard is acting as the financial advisor to the Special Committee of ARRAY in connection with a transaction.
Lazard Completes Acquisition of Campbell Lutyens and Launches Lazard CL
Lazard, Inc. has finalized its acquisition of Campbell Lutyens and introduced a new division, Lazard CL, focused on private capital advisory.
Lazard Serves as Financial Advisor to Xerox in Debt Exchange Transaction
Lazard is acting as the financial advisor to Xerox Holdings Corporation in a transaction to exchange a portion of its 2028 debt maturities for new notes and common stock.